SEATTLE, July 31 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX) has
scheduled a presentation at the following investor conferences in August 2001.
The conferences, their respective dates and locations are as follows:
-- Adams, Harkness & Hill - 21st Annual Summer Seminar
Wednesday, August 1, 2001
Boston, Massachusetts
-- Annual Immunex Research & Development Update
Monday & Tuesday, August 20 & 21, 2001
Seattle, Washington
For information about available webcasts and replays, visit the Investor
Relations page on the Immunex website at http://www.immunex.com/investor_fs3.html.
Immunex Corporation is a leading biopharmaceutical company dedicated to
improving lives through immune system science innovations.
NOTE: Except for the historical information contained herein, this news
release contains forward-looking statements that involve substantial risks and
uncertainties. Among the factors that could cause actual results or timelines
to differ materially are risks associated with research and clinical
development, regulatory approvals, our supply capabilities and reliance on
third-party manufacturers, product commercialization, competition, litigation
and other risk factors listed from time to time in reports filed by Immunex
with the SEC, including but not limited to risks described under the caption
"Important Factors That May Affect Our Business, Our Results of Operations and
Our Stock Price" within our most recently filed Form 10-Q. The forward-
looking statements contained in this news release represent our judgment as of
the date of this release. Immunex undertakes no obligation to publicly update
any forward-looking statements. An electronic version of this news release --
as well as additional information about Immunex of interest to investors,
customers, future employees and patients -- is available on the Immunex home
page at http://www.immunex.com.
SOURCE Immunex Corporation
 back to top
Related links:
http://www.immunex.com
Company News On-Call:
http://www.prnewswire.com/gh/cnoc/comp/434644.html
CONTACT:
media, Robin Shapiro, +1-206-389-4040, or
investors, Mark Leahy, +1-206-389-4363, both of Immunex
Corporation
|
